Source comparison
MOTS-c Results After 1 Week: Dosage & Timeline Comparison
5mg subcutaneous 3× weekly AMPK activation within 48–72 hours; glucose uptake improved 12–18% in muscle tissue No visible fat loss; possible 1–3 lb water weight drop from glycogen depletion 4–6 weeks for body composition changes; 6–8 weeks for endurance perfor
This comparison does not assign a generated winner or score.
- 5mg subcutaneous 3× weekly
- AMPK activation within 48–72 hours; glucose uptake improved 12–18% in muscle tissue
- No visible fat loss; possible 1–3 lb water weight drop from glycogen depletion
- 4–6 weeks for body composition changes; 6–8 weeks for endurance performance
- Standard research dose. Realistic expectations required
- 10mg subcutaneous 2× weekly
- Same AMPK timeline; slightly higher peak plasma concentration but similar total weekly exposure
- No visible fat loss; some users report energy stability by day 5–7
- 4–6 weeks for fat oxidation benefits; 8–10 weeks for insulin sensitivity plateau
- Higher per-dose concentration. No evidence of faster results
- 15mg once weekly
- AMPK activation occurs but less sustained between doses; potential receptor downregulation
- No visible outcomes; less stable blood glucose vs split dosing
- 6–8 weeks minimum; single-dose protocols underperform split dosing in animal models
- Not recommended. Less frequent dosing reduces metabolic consistency
- The comparison underscores a critical point: higher doses or different schedules do not accelerate MOTS-c results after 1 week. The peptide's mechanism depends on sustained AMPK activation over time, not peak plasma levels during any single week.